-
-
-
-
-
-
-
Gilead to present lenacapavir HIV trial data at AIDS 2026
-
-
-
-
-
-
-
EMD Serono names new global commercial head and North America president
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
-
-
-
-
-
-
Merck completes $5.8 billion acquisition of Terns Pharmaceuticals
-
-
-
-
-
-
-
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
-
-
-
-
-
-
-
TD Cowen Downgrades Terns Pharmaceuticals (TERN) to Hold
-
-
-
-
-
-
-
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal
-
1,194,859 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

